► Customized research for RLMD vs. LBLTF!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for RLMD vs. LBLTF.
↗ Join Our Free Email Newsletter.
► Relmada Therapeutics, Inc. vs. Lattice Biologics Ltd.
Industry Match! Industry of Both RLMD and LBLTF:
Health Care/Life Sciences
RLMD
Data Last Updated: 2 days ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 345M
P/E: N/A
P/S: N/A
Q P/B: 57.69
Y Rev: -
Q Rev: -
Beta: -0.09

RLMD Share Stats
► Outstanding Shares
33.26M
► Float Shares
12.05M
► Percent of Float Short
3.15%
RLMD Insider Stats
► Percent Outstanding Insider Ownership
7.07%
► Percent Outstanding Institution Ownership
0%
RLMD Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share RLMD Insights
RLMD Profile
► CEO
Dr. Sergio Traversa
► Exchange
Nasdaq
► Employees
4.00
► About
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and...

RLMD Financials
Annual Financials
Income Statement
► Revenue
-
► Net Income
(17.32M)
Cash Flow Statement
► Change in Cash / Investments
6.98M
Balance Sheet
► Cash / Investments
9.22M
► Short Term Debt
364,204
► Long Term Debt
None
► Total Current Assets
9.98M
► Total Current Liabilities
2.61M
► Total Assets
10.22M
► Total Liabilities
2.61M
► Stockholder Equity
7.61M
Quarterly Financials
Income Statement
► Q Revenue
-
► Q Net Income
(3.67M)
Cash Flow Statement
► Q Change in Cash / Investments
(1.37M)
Balance Sheet
► Q Cash / Investments
7.85M
► Q Short Term Debt
255,925
► Q Long Term Debt
None
► Q Total Current Assets
8.3M
► Q Total Current Liabilities
2.54M
► Q Total Assets
8.51M
► Q Total Liabilities
2.54M
► Q Stockholder Equity
5.98M

RLMD Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

LBLTF
Data Last Updated: 13 hours ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 1.8M
P/E: N/A
P/S: 1.22
Q P/B: N/A
Y Rev: 1.48M
Q Rev: 599,355
Beta: 1.14

LBLTF Share Stats
► Outstanding Shares
N/A
► Float Shares
69.76M
► Percent of Float Short
N/A
LBLTF Insider Stats
► Percent Outstanding Insider Ownership
0%
► Percent Outstanding Institution Ownership
0.53%
LBLTF Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share LBLTF Insights
LBLTF Profile
► CEO
Mr. Guy S. Cook
► Exchange
OTC
► Employees
N/A
► About
Lattice Biologics, Ltd. is a biotech company which engages in cellular therapies and tissue engineering, with a focus on bone, skin, and cartilage regeneration. Its products include allograft amniotic fluid viscosupplement, traditional allografts, spinal allografts,...

LBLTF Financials
Annual Financials
Income Statement
► Revenue
1.48M
► Net Income
(1.58M)
Cash Flow Statement
► Change in Cash / Investments
(15,884)
Balance Sheet
► Cash / Investments
8,335
► Short Term Debt
10,765
► Long Term Debt
904,967
► Total Current Assets
2.17M
► Total Current Liabilities
9.01M
► Total Assets
3.96M
► Total Liabilities
10.84M
► Stockholder Equity
(6.88M)
Quarterly Financials
Income Statement
► Q Revenue
599,355
► Q Net Income
(389,608)
Cash Flow Statement
► Q Change in Cash / Investments
7,494
Balance Sheet
► Q Cash / Investments
7,752
► Q Short Term Debt
None
► Q Long Term Debt
968,513
► Q Total Current Assets
2.14M
► Q Total Current Liabilities
9.32M
► Q Total Assets
3.83M
► Q Total Liabilities
11.2M
► Q Stockholder Equity
(7.38M)

LBLTF Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

